European Radiology:I期肺癌的术前穿刺活检技术与同侧胸膜复发的关系

2022-04-06 shaosai MedSci原创

胸膜复发是PTNB的一种罕见的、潜在的长期并发症。在术前PTNB后接受早期肺癌治愈性切除的患者中,同侧肺癌的胸膜复发频率高于未接受PTNB的患者,这是一个值得关注的问题。

 由于低剂量计算机断层扫描(CT)筛查早期肺癌的普及,肺结节的发现率显著提高。当CT图像上检测到结节时,处理原则取决于恶性肿瘤的风险,对有肺癌风险的结节进行病理诊断对于指导适当的治疗至关重要。经皮经胸针肺活检(PTNB)被广泛用于肺癌的病理诊断,诊断肺癌提供了较高的准确性。PTNB最常见的并发症是气胸,其次是咯血和肺出血。

胸膜复发是PTNB的一种罕见的、潜在的长期并发症。在术前PTNB后接受早期肺癌治愈性切除的患者中,同侧肺癌的胸膜复发频率高于未接受PTNB的患者,这是一个值得关注的问题。众所周知,胸膜复发的危险因素取决于肺癌的特点,包括体积较大、胸膜下位置、伴有脏胸膜浸润或病理检查中的微小淋巴侵犯。如果术前PTNB与胸膜复发的发生有关,那么一些程序因素可能会影响胸膜复发的风险,但临床上缺少对这种因素的相关研究

近日,发表在European Radiology杂志的一项研究探讨了特定的PTNB技术是否会降低I期肺癌治愈性切除术后同侧胸膜复发的风险,为该技术的进一步广泛应用铺平了道路

本研究回顾性地纳入了415名从2009年到2016年连续接受术前PTNB和治愈性切除的I期肺癌患者,收集了详细的信息,包括肺癌的临床、PTNB技术、放射学和病理学特征。进行Cox回归分析以确定倾向性评分匹配前后胸膜复发的风险因素。 

PTNB后的总随访期为62.1±23.0个月,40名患者发生同侧胸膜复发。在倾向评分匹配前,年龄(p = 0.063)、显微镜下胸膜侵犯(p = 0.065)和病理肿瘤大小(p = 0.016)在单变量分析中倾向于与胸膜复发相关,随后使用倾向评分进行匹配。倾向评分匹配后,多变量分析显示,同侧胸膜复发与CT的目标尺寸较大(危险比[HR]=1.498;95%CI,1.506-2.125;p=0.023)和显微镜下淋巴侵犯(HR=3.526;95%CI,1.491-8.341;p=0.004)有关。然而,没有任何PTNB技术,如针距、活检或胸膜通道数与复发风险的降低有关。  

 根据(a)计算机断层扫描(CT)上的目标尺寸和(b)显微镜下的淋巴侵犯,倾向评分匹配后的无复发生存率的Kaplan-Meier图。

总之,在使用PSM调整肿瘤和患者特征后,没有特定的PTNB技术可以减少I期肺癌PTNB后的同侧胸膜转移。无论采用何种具体技术,当怀疑是早期肺癌时,需要谨慎地应用PTNB,然后进行根治性手术治疗。

原文出处

Min Gwan Kim,Bo Ram Yang,Chang Min Park,et al.Preoperative percutaneous needle lung biopsy techniques and ipsilateral pleural recurrence in stage I lung cancer.DOI:10.1007/s00330-021-08359-x

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1666322, encodeId=6b10166632242, content=<a href='/topic/show?id=bbaf8420118' target=_blank style='color:#2F92EE;'>#胸膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84201, encryptionId=bbaf8420118, topicName=胸膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc026056217, createdName=lifestar, createdTime=Thu May 26 05:47:54 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729471, encodeId=13281e2947198, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Nov 11 04:47:54 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005309, encodeId=94f72005309f3, content=<a href='/topic/show?id=0f4de5432ce' target=_blank style='color:#2F92EE;'>#穿刺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75432, encryptionId=0f4de5432ce, topicName=穿刺活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Jun 23 00:47:54 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217860, encodeId=e4e5121e8606e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19488152558, createdName=ms9000001092967069, createdTime=Sun May 08 15:11:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278267, encodeId=d7f912e826746, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311975, encodeId=983f13119e5f5, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-05-26 lifestar
  2. [GetPortalCommentsPageByObjectIdResponse(id=1666322, encodeId=6b10166632242, content=<a href='/topic/show?id=bbaf8420118' target=_blank style='color:#2F92EE;'>#胸膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84201, encryptionId=bbaf8420118, topicName=胸膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc026056217, createdName=lifestar, createdTime=Thu May 26 05:47:54 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729471, encodeId=13281e2947198, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Nov 11 04:47:54 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005309, encodeId=94f72005309f3, content=<a href='/topic/show?id=0f4de5432ce' target=_blank style='color:#2F92EE;'>#穿刺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75432, encryptionId=0f4de5432ce, topicName=穿刺活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Jun 23 00:47:54 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217860, encodeId=e4e5121e8606e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19488152558, createdName=ms9000001092967069, createdTime=Sun May 08 15:11:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278267, encodeId=d7f912e826746, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311975, encodeId=983f13119e5f5, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-11-11 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1666322, encodeId=6b10166632242, content=<a href='/topic/show?id=bbaf8420118' target=_blank style='color:#2F92EE;'>#胸膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84201, encryptionId=bbaf8420118, topicName=胸膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc026056217, createdName=lifestar, createdTime=Thu May 26 05:47:54 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729471, encodeId=13281e2947198, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Nov 11 04:47:54 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005309, encodeId=94f72005309f3, content=<a href='/topic/show?id=0f4de5432ce' target=_blank style='color:#2F92EE;'>#穿刺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75432, encryptionId=0f4de5432ce, topicName=穿刺活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Jun 23 00:47:54 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217860, encodeId=e4e5121e8606e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19488152558, createdName=ms9000001092967069, createdTime=Sun May 08 15:11:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278267, encodeId=d7f912e826746, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311975, encodeId=983f13119e5f5, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1666322, encodeId=6b10166632242, content=<a href='/topic/show?id=bbaf8420118' target=_blank style='color:#2F92EE;'>#胸膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84201, encryptionId=bbaf8420118, topicName=胸膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc026056217, createdName=lifestar, createdTime=Thu May 26 05:47:54 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729471, encodeId=13281e2947198, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Nov 11 04:47:54 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005309, encodeId=94f72005309f3, content=<a href='/topic/show?id=0f4de5432ce' target=_blank style='color:#2F92EE;'>#穿刺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75432, encryptionId=0f4de5432ce, topicName=穿刺活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Jun 23 00:47:54 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217860, encodeId=e4e5121e8606e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19488152558, createdName=ms9000001092967069, createdTime=Sun May 08 15:11:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278267, encodeId=d7f912e826746, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311975, encodeId=983f13119e5f5, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-05-08 ms9000001092967069

    学习了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1666322, encodeId=6b10166632242, content=<a href='/topic/show?id=bbaf8420118' target=_blank style='color:#2F92EE;'>#胸膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84201, encryptionId=bbaf8420118, topicName=胸膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc026056217, createdName=lifestar, createdTime=Thu May 26 05:47:54 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729471, encodeId=13281e2947198, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Nov 11 04:47:54 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005309, encodeId=94f72005309f3, content=<a href='/topic/show?id=0f4de5432ce' target=_blank style='color:#2F92EE;'>#穿刺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75432, encryptionId=0f4de5432ce, topicName=穿刺活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Jun 23 00:47:54 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217860, encodeId=e4e5121e8606e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19488152558, createdName=ms9000001092967069, createdTime=Sun May 08 15:11:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278267, encodeId=d7f912e826746, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311975, encodeId=983f13119e5f5, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1666322, encodeId=6b10166632242, content=<a href='/topic/show?id=bbaf8420118' target=_blank style='color:#2F92EE;'>#胸膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84201, encryptionId=bbaf8420118, topicName=胸膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc026056217, createdName=lifestar, createdTime=Thu May 26 05:47:54 CST 2022, time=2022-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729471, encodeId=13281e2947198, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Nov 11 04:47:54 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005309, encodeId=94f72005309f3, content=<a href='/topic/show?id=0f4de5432ce' target=_blank style='color:#2F92EE;'>#穿刺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75432, encryptionId=0f4de5432ce, topicName=穿刺活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Jun 23 00:47:54 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217860, encodeId=e4e5121e8606e, content=学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19488152558, createdName=ms9000001092967069, createdTime=Sun May 08 15:11:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278267, encodeId=d7f912e826746, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311975, encodeId=983f13119e5f5, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Wed Apr 06 23:47:54 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-06 rgjl

相关资讯

Radiology:哪种乳腺穿刺活检好?

本研究旨在比较垂直乳腺断层成像(DBT)引导下真空辅助乳腺活检(VABB)与俯卧位立体定向(PS)VABB的效果。

Int J Oral Max Surg:颈淋巴结肿大和涎腺肿瘤粗针穿刺活检与细针抽吸细胞学检查的疗效和安全性分析

本研究比较了细针穿刺细胞学和粗针穿刺活检对颈淋巴结肿大或唾液腺肿瘤患者的诊断准确性和安全性,并为临床选择合适的诊断方法提供了依据。

Lancet:前列腺穿刺活检前的筛查检测——多参数磁共振成像MP-MRI

血清前列腺特异性抗原水平较高的男性经常需要接受直肠超声引导下的前列腺穿刺活检。经直肠超声引导下前列腺穿刺活检术(transrectal ultrasound-guided prostate biopsy,TRUS-Bx)现已成为检测及管理前列腺癌的主要手段,是诊断前列腺癌的“金标准”。然而TRUS-Bx会造成一些副作用如:出血、疼痛和感染。昨日在线发表于Lancet上的一项研究表明:多参数磁共振成

Radiology:超声引导细针穿刺活检甲状腺恶性肿瘤价值知多少!

本研究旨在比较七个国际协会的超声引导下细针穿刺活检 (FNAB) 标准对甲状腺恶性肿瘤的诊断性能。